Peer Review History

Original SubmissionMay 12, 2020
Decision Letter - Yu-Chi Liu, Editor

PONE-D-20-10509

Clinical outcomes after small incision lenticule extraction versus femtosecond laser-assisted LASIK for high myopia: a Meta-analysis.

PLOS ONE

Dear Dr. Wen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but several points have to be addressed before it can be further considered. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Yu-Chi Liu, M.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note your manuscript is currently in landscape as opposed to portrait layout, could you please update the layout to portrait.

3. Please ensure that all search terms and combinations and the complete search strategy have been provided in the Methods section and/or Supplemental information.

4.We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript
  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)
  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

5. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript summarizes clinical outcomes after small incision lenticule extraction versus femtosecond laser assisted LASIK for high myopia using meta-analysis. I have below questions and comments.

Table 1. It’s not clearly described what the numbers are under SE(D) are. Which number is SE? What’s SE or D?

The funnel plot (Supplementary Figure 1) with statistical test results are not robust because tests for funnel plot asymmetry should not be used when the number of studies is less than 10.

Table 3, What CH?(P<0.001)? What are those numbers are under SMILE or FS-LASIK?

In Figures 3 and 4, please add note/legend to clearly indicate which outcome is summarized under figure A, B, C or D.

Line 171, “All of these 10 included studies were retrospective non-random control trials”. Some of these trials are prospective trials. Please double check.

What are the potential reasons that such trials only performed or reported from Asia?

The font size is too small to review conveniently. Please increase the font size in revisions.

Authors please ask an English editor to edit the writing in English.

Reviewer #2: General comments:

#1 The authors have tried to perform a meta analysis on clinical outcomes of SMILE versus FS-LASIK for high myopia. Such initiatives are welcome, but unfortunately very few well-performed RCTs have been performed. Maybe just one...

#2 I think the authors should focus on one outcome, maybe three clinical outcomes: Safety, efficacy and predictability, and focus their manuscript on these aspects. They should leave out biomechanics changes, aberrations etc. This will make the manuscript more clear (see Specific comments).

#3 The vast majority of included studies are based on Chinese patients. This should be discussed.

#4 The manuscript needs to be revised by a native English person.

Specific comments:

#5 Line 68: Please correct that publications up to November 2019 were included.

#6 Line 223 : Drop "Biomechanical effects"

#7 Line 249 ff: Drop discussion on "glare" as this was not primary outcome.

#8 Line 254: Drop discussion on trauma.

#9 Line 259: Drop discussion on "wound healing"

#10 Line 266: Drop discussion on posterior cornea, as this was not investigated.

#11 Line 277: Drop discussion on contest sensitivity, as this was not investigated.

#12 Line 283: Drop discussion on biomechanics changes.

#13 Line 287: Drop discussion on PCE, as this was investigated.

Reviewer #3: This is an important Meta Analysis, and one that has been carried out carefully by the authors. The only question i have is how the authors have left out one study in one context (for looking at UDVA) and used it in another context (HOA's).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Rupal Shah

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We have revised the manuscript according to editors’ comments.

1. Some format has been modified according to PLOS ONE's style requirements.

2. Since the table1 page layout, except table1 other pages layout have been modified to portrait.

3. All search terms and combinations and the complete search strategy have been provided in the revised version Methods section.

4. We have employed a professional scientific editing service (AJE) according to your recommendation to modify the language editing, translation, manuscript formatting, and figure formatting, the “AJE Editing Certificate” was also uploaded in the Supplemental information.

5. Our ethics statement have been added in the Methods section of revised version manuscript.

6. Because of the time interval, we have re-searched all the databases and add two included studies to this meta- analysis according to the screening process, Except for CDVA, there was no significant change in other results.

Reviewer #1: This manuscript summarizes clinical outcomes after small incision lenticule extraction versus femtosecond laser assisted LASIK for high myopia using meta-analysis. I have below questions and comments.

Table 1. It’s not clearly described what the numbers are under SE(D) are. Which number is SE? What’s SE or D?

Answer: SE means postoperative mean refractive spherical equivalent, and D means diopter. All values in the “SE(D)” column represent the postoperative mean refractive spherical equivalent in diopters. We have revised “SE(D)” to “Preop mean SE (D)” and added comments below Table 1.

The funnel plot (Supplementary Figure 1) with statistical test results are not robust because tests for funnel plot asymmetry should not be used when the number of studies is less than 10.

Answer: We have removed Supplementary Figure 1.

Table 3, What CH?(P<0.001)? What are those numbers are under SMILE or FS-LASIK?

Answer: To make this manuscript clearer, we have left out biomechanical parameters including posterior corneal elevation (PCE) changes as well as CH and CRF values.

In Figures 3 and 4, please add note/legend to clearly indicate which outcome is summarized under figure A, B, C or D.

Answer: We have added notes under Figures 3 and 4.

Line 171, “All of these 10 included studies were retrospective non-random control trials”. Some of these trials are prospective trials. Please double check.

Answer: We have checked and modified it (lines 242-243).

What are the potential reasons that such trials only performed or reported from Asia?

Answer: We have added the following explanation (lines 414-416): “… the processed screening results showed that most of the included studies were performed in China, which may have caused publication bias.”

The font size is too small to review conveniently. Please increase the font size in revisions.

Answer: We have standardized the font size.

Authors please ask an English editor to edit the writing in English.

Answer: We have invited a scientific editor at American Journal Experts (AJE) to edit the English in our manuscript.

Reviewer #2: General comments:

#1 The authors have tried to perform a meta analysis on clinical outcomes of SMILE versus FS-LASIK for high myopia. Such initiatives are welcome, but unfortunately very few well-performed RCTs have been performed. Maybe just one...

Answer: We have added the following explanation (lines 413-414): “… only one randomized trial was included, which increased the risk of various types of bias.”

#2 I think the authors should focus on one outcome, maybe three clinical outcomes: Safety, efficacy and predictability, and focus their manuscript on these aspects. They should leave out biomechanics changes, aberrations etc. This will make the manuscript more clear (see Specific comments).

Answer: To make this manuscript clearer, we have left out biomechanical parameters including posterior corneal elevation (PCE) changes as well as CH and CRF values.

#3 The vast majority of included studies are based on Chinese patients. This should be discussed.

Answer: We have added the following explanation: “… the processed screening results showed that most of the included studies were performed in China, which may have caused publication bias.”

#4 The manuscript needs to be revised by a native English person.

Answer: We have invited a scientific editor at American Journal Experts (AJE) to edit the English in our manuscript.

Specific comments:

#5 Line 68: Please correct that publications up to November 2019 were included.√

PS: We performed the literature searches from March 2018 to July 2020; we did not mean to imply that the latest publication was from July 2020.

#6 Line 223 : Drop "Biomechanical effects"√

#7 Line 249 ff: Drop discussion on "glare" as this was not primary outcome. √

#8 Line 254: Drop discussion on trauma. √

#9 Line 259: Drop discussion on "wound healing"√

#10 Line 266: Drop discussion on posterior cornea, as this was not investigated. √

#11 Line 277: Drop discussion on contest sensitivity, as this was not investigated. √

#12 Line 283: Drop discussion on biomechanics changes. √

#13 Line 287: Drop discussion on PCE, as this was investigated. √

Reviewer #3: This is an important Meta Analysis, and one that has been carried out carefully by the authors. The only question i have is how the authors have left out one study in one context (for looking at UDVA) and used it in another context (HOA's).

Answer: That study (Likun Xia et al. [11]) showed an outsized influence on the results in the “leave-one-out” analysis for UDVA (I2=69% when included, but I2=0% when excluded). However, the “leave-one-out” analyses for tHOA, spherical aberration and coma did not show that those outcomes were highly sensitive to Xia et al. In addition, the results of the statistical analysis were the same whether that study was included or excluded.

Attachments
Attachment
Submitted filename: Response_to_Reviewers.docx
Decision Letter - Yu-Chi Liu, Editor

PONE-D-20-10509R1

Clinical outcomes after small incision lenticule extraction versus femtosecond laser-assisted LASIK for high myopia: a meta-analysis

PLOS ONE

Dear Dr. Wen,

Thank you for submitting your manuscript to PLOS ONE. We invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 08 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Yu-Chi Liu, M.D

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: My comments have been addressed, but the abstract have an error which needs to be corrected: In the Results section, the authors write "Pooled results revealed no significant differences ..., the logMAR of postoperative corrected distance visual acuity (CDVA; WMD=-0.04, 95% CI, -0.05 to 0.02, I2=0%, P<0.00001), ..." Think the correct 95% CI is -0.05 to -0.02, which the P value also indicate, and this is also written in the Results section in the manuscript.

Thus, the sentence needs to be corrected.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Reviewer #1: (No Response)

Reviewer #2: My comments have been addressed, but the abstract have an error which needs to be corrected: In the Results section, the authors write "Pooled results revealed no significant differences ..., the logMAR of postoperative corrected distance visual acuity (CDVA; WMD=-0.04, 95% CI, -0.05 to 0.02, I2=0%, P<0.00001), ..." Think the correct 95% CI is -0.05 to -0.02, which the P value also indicate, and this is also written in the Results section in the manuscript.

Thus, the sentence needs to be corrected.

Answer: We have corrected the Results section in abstract. (line88-93)

Reviewer #3: (No Response)

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Yu-Chi Liu, Editor

PONE-D-20-10509R2

Clinical outcomes after small incision lenticule extraction versus femtosecond laser-assisted LASIK for high myopia: a meta-analysis

PLOS ONE

Dear Dr. Wen,

Thank you for submitting your manuscript to PLOS ONE. We invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 14 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Yu-Chi Liu, M.D

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Please check the accuracy of the statistics the reviewer mentioned. The P value is significant but the CI includes 0.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 3

Additional Editor Comments (if provided):

Please check the accuracy of the statistics the reviewer mentioned. The P value is significant but the CI includes 0.

Answer: We have modified all the place that CI values was incorrect.

Attachments
Attachment
Submitted filename: Response to Reviewers03.docx
Decision Letter - Yu-Chi Liu, Editor

Clinical outcomes after small-incision lenticule extraction versus femtosecond laser-assisted LASIK for high myopia: a meta-analysis.

PONE-D-20-10509R3

Dear Dr. Wen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yu-Chi Liu, M.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Yu-Chi Liu, Editor

PONE-D-20-10509R3

Clinical outcomes after small-incision lenticule extraction versus femtosecond laser-assisted LASIK for high myopia: a meta-analysis.

Dear Dr. Wen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yu-Chi Liu

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .